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We report the first use of an emission probe based on the Cu(I)-thiolate chromophore, for the direct observation of copper metallothionein located 
in samples of rat liver. Elevated synthesis of Cu-MT in the rat liver was induced by subcutaneous injections of a series of aqueous CuCl, solutions 
containing increasing amounts of Cu(I1). Luminescence intensity in the 600 nm region, detected from frozen solutions of Cu-MT and from slices 
of the liver frozen at 77 K, following excitation in the 300 nm region, was dependent on the concentration of the Cu(II) used in the inducing solution. 
No such luminescence mtensity was found for control samples obtained from the livers of rats not exposed to copper salts. It is suggested that 
this new method will allow direct visualization of Cu-MT in tissue where genetic disorders impare copper metabolism. 
Metallothionein; Copper binding; Light emission; Wilson’s disease; (Rat liver tissue) 
1. INTRODUCTION for Cu are unreliable because both Zn and Fe interfere 
WI * 
The protein metallothionein (MT) is found in all 
mammalian organs [1,2]. While the specific role of 
metallothionein has not been defined, elevated concen- 
trations of the protein are detected in the liver and 
kidneys following exposure to the ions of cadmium, 
zinc and copper [ 11. Metallothionein concentrations are 
also increased in human livers of subjects suffering 
from Wilson’s or Menke’s diseases [3,4]. About 
50-80% of all Cu is bound to MT in Wilson’s patient’s 
liver [5] and to MT stimulated in liver by the injection 
of Cu salts [6]. An error in copper metabolism is also 
considered to be the cause of a debilitating, hereditory 
disease of Bedlington Terriers; high levels of copper 
have been found in the livers of these dogs [7]. Very 
special cluster binding has been demonstrated for cad- 
mium and zinc [8-141, and has been suggested for cop- 
per and mercury [ 12,15,16]. Species with the stoichio- 
metric ratios of 7 and 12, illustrated by Cd-I-MT, 
CUIZ-MT and HgT-MT, have been characterized spec- 
troscopically [ 12,13,16], while X-ray diffraction studies 
on the Cds,Zn2-MT complex [9] have been completed. 
It has been shown that Cu-MT, in which copper(I) is 
chelated by thiolate groups, emits orange light when il- 
luminated with UV light at room temperature and 
below [ 12,17-191. This Cu(I)-MT luminescence is 
predominantly cluster dependent [ 121. Existing 
methods of detecting excess copper in liver by staining 
We now report the first use of this emission probe for 
the direct observation of copper metallothionein in 
tissue samples from rat liver and human liver. With ex- 
citation of the Cu-MT complexes in the 300 nm region 
we avoid the interference in tissue from a strong, por- 
phyrin absorption which has a maximum near 400 nm. 
The very large Stoke’s shift places the Cu-MT emission 
near 600 nm, which is to the red of the natural 
luminescence from the tissue, which would otherwise 
completely block the observation of the Cu-MT emis- 
sion. We find that the intensity of the emission from rat 
liver depends on the concentration of Cu(I1) in the in- 
ducing solution. 
2. EXPERIMENTAL 
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Copper-metallothionein synthesis was induced infemale rats that 
were injected with aqueous CuC12 solution, seven times, every second 
day, over a two week period, with doses of 1, 2, and 3 mg of Cu per 
kg body wt. We have found no reports of the specific induction of 
other copper(I)-containing proteins in liver tissue following a regimen 
such as this, when the animals are fed a normal diet. The control rat 
was subcutaneously injected with saline solution instead of the CuC12 
solution. The animals were killed under phenobarbital narcosis, and 
the kidneys and livers removed and immediately frozen in liquid 
nitrogen. Copper in the liver was determined using AAS methods, 
after digestion of the tissue in a mixture of HNO3 and HC104. 
Metallothionein was estimated using the mercury binding method 
[22]; whereas the concentration of mercury was determined by AAS. 
The method was calibrated by adding a standard solution of 
metallothionein which contained 6 Cu ions per molecule of MT. For 
a 3 mg/kg body wt regimen, the copper and MT levels were 
significantly enhanced in liver tissue. A value of 58 * 10 pg of Cu 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 283 
Volume 257, number 2 FEBS LETTERS November 1989 
and 134 +_ 30&g of MT per g of wet liver tissue was found in the liver 
of 3 mg-G-treated rats, which can be compared to the vafues of 
2.0 f 0.488 of Cu and 41 + 1 pg of MT per g of wet liver tissue that 
were determined for the control rat. 
Frozen human liver samples were obtained from Dr M.G. Cherian, 
Department of Pathology, University of Western Ontario. The liver 
from the Wilson’s disease patient had 197 I 2 gg of Cu and 629 fig 
of MT per g of wet tissue, while the control liver contained 5.1 & 0.2 
gg of Cu and 536 pg of MT per g of wet tissue. 
The distribution of copper and MT in the rat liver samples was 
analysed by gel chromatography. The analysis of the eluate showed 
that an estimated 65% of the total copper is bound to metallothio- 
nein. The increased copper and MT concentrations are in complete 
agreement with previous studies on the inducement of Cu-MT in rat 
livers [6-211. It has been reported [6] that on average 5-6 Cu and 0.5 
Zn are bound to metailothionein located in the livers of rats that have 
been injected with copper salts. 
Control spectra (not shown here) were measured using G-MT 
prepared from &-MT, which was isolated from rabbit liver follow- 
ing the in vivo induction procedures described previously with Zn2+ 
salts 1221. A 20 nmol/ml solution of Zn,-MT (isoform 2) in water, was 
titrated with 6 mol equivalents of Cu+ (Cu(CHs~N~ in 70% water/ 
acetonitrife solution) to form the mixed-metal, Zn,Cu-MT, with in- 
creasing fractions of copper(I) bound to the MT. Solutions of the 
Zn,Cu-MT complexes were frozen and the emission spectra measured 
at 77 K. The human and rat livers were sliced and transferred into a 
quartz Dewar filled with liquid nitrogen. Emission spectra nd excited 
state lifetime data were recorded using Perkin-Elmer MPF 4 and 
Photon Technology Inc. LSI spe~trofuorometers. The spectral data 
were manipulated and plotted on an HP 755OA plotter using the data 
management program Spectra Manager [23]. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the uncorrected emission spectra from 
liver isolated from a rat that had been treated only with 
saline. The spectra were obtained as a function of ex- 
citation wavelength, from a sample of rat liver, frozen 
at 77 K, after excitation in the range of 280-350 nm. 
Fig.2 shows the corresponding emission spectra obtain- 
Fig.1. Uncorrected emission spectra from a whole liver sample, 
isolated from a control rat, after excitation in the range of 280-350 
nm at 77 K. 
Fig.2. Uncorrected emission spectra from a whole liver sample, 
isolated from a copper-treated (2 mg/kg body wt) rat, after excitation 
in the range of 280-350 nm at 77 K. 
ed from liver tissue isolated from a rat treated with a 
solution containing 2 mglkg body wt. (Emission from 
a rat treated with I mg/kg copper was much less in- 
tense, but still significantly greater than for the con- 
trol). Clearly, new and intense luminescence grows 
when the rat is treated with copper. This band exhibits 
a maximum near 605 nm when excited with light of 3 10 
nm wavelength. Significantly, there is minimal 
luminescence observed from the liver sample isolated 
from the rat exposed solely to saline when this exciting 
wavelength is used. The copper-induced emission band 
closely resembles that reported for Cu-MT formed in 
vitro [ 191. The dips near 550 nm in the emission intensi- 
ty recorded following excitation at 310 nm, for the ‘2 
mg/kg’ tissue, represent reabsorption of the emitted 
light by heme proteins in the tissue. This is not a prob- 
lem further to the red (560-700 nm) because protopor- 
phyrin IX does not absorb light in this region, so the in- 
tensity of the main emission band is relativeIy unaf- 
fected. 
Enhanced emission intensity was also observed when 
the emission from liver tissue isolated from a Wilson’s 
disease patient was compared with tissue isolated from 
a human subject not affected by Wilson’s disease. We 
believe that the additional emission intensity in the 550 
to 600 nm region from the Wilson’s disease liver also 
arises from CuMT. 
Our previous studies [12,19] of the emission spectra 
of rat liver Cu-MT 2 formed in vitro, have established 
that the emission maxima for the Cu(I)-S chromophore 
lie near 600 nm, and that the lifetime of the emitting 
state is highly dependent on temperature. Emission 
spectra recorded at room temperature during titrations 
of ZnT-MT 2 with Cu(1) [12] demonstrate a strong 
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dependence of the emission intensity on the stoichio- 
metric ratio, with a maximum being observed for 
Curz-MT in agreement with spectroscopic data on the 
Cu-S cluster formation in MT [12,15]. In frozen solu- 
tions at low temperature, we have found [24] that the 
emission spectrum is very much dependent on both the 
stoichiometric ratio of Cu to MT, and on the nature of 
the MT used at the beginning of the titration, that is 
whether it was ZnT-MT or apo-MT. Emission spectra 
for Cue-MT at 77 K have maxima at 550 and 640 nm, 
reflecting the heterogenity of the copper(I) excited state 
1191. 
The excited state lifetime studies provide an addi- 
tional assignment criterion. Fig.3 shows a series of 
traces illustrating the decay of luminescence from the 
control and Cu-treated rat livers at 77 K. The 
luminescence decay from Cu-treated liver is bi-phasic. 
Deconvolution of the luminescence decays for livers 
isolated from Cu-treated rats at wavelengths of 590-610 
nm, when excited in the range 290-310 nm, consistently 
yielded a contribution of two components to the decay 
curve. A short-lived component had a lifetime of 
11 + 1 pus and the long-lived component showed the 
lifetime of 98 + 6 ,us. The luminescence decay from the 
control sample at 77 K showed only a fast component 
with a lifetime of about 9 ,US. The luminescence decay 
from model Cu-MT complexes at 77 K always yields 
lifetimes in the 100 ps range, but the decays are 
heterogenous and depend on the Cu content. For exam- 
ple, the luminescence decay from Cure-MT at 77 K can 
be deconvoluted into two exponential components with 
lifetimes of 63 f 1 PCS and 132 f 30 PCS [24]. 
Thus the luminescence decay in the 600 nm region 
from the livers of Cu-treated rats can be characterized 
\ 
RAT LIVER 77 K 
Fig.3. Excited state luminescence decays at 610 nm from a whole liver 
sample, isolated from a copper-treated rat with 2 mg Cu/kg body wt 
and 3 mg Cu/kg body wt, and from a whole liver sample, isolated 
from a control rat, after excitation at 300 nm at 77 K. 
as a superposition of a nonspecific background 
luminescence with a lifetime shorter than lops, and a 
luminescence that is typical of the excited states in Cu- 
MT with a lifetime of the order of 100~s. 
The photophysical properties of the Cu-MT emitter 
in liver can be compared to rare earth chelates used as 
labels in fluorometric measurements [25]. The com- 
bination of these two unusual properties, (i) a large 
Stokes shift and (ii) a long luminescence decay time, 
provides the basis for use of the emitting Cu-MT in liver 
as an excellent internal imaging label. The time resolu- 
tion method can be readily exploited to distinguish bet- 
ween background luminiscence and the Cu-emitting 
centers. 
Although a variety of different metallated MT com- 
plexes have been studied spectroscopically in vitro, no 
reports of the direct spectroscopic observation of MT in 
vivo have appeared to date. The commonly accepted 
methods for detecting MT in vivo include use of im- 
munological probes. Despite their high sensitivity, these 
probes offer no sensitivity with respect to the metal 
bound to the protein. The lack of direct observation of 
metallated metallothioneins by other techniques is due, 
in part, to the lack of readily available, spectroscopic 
chromophores with which to observe the protein. There 
are no aromatic amino acids in MT, and the group 11 
and 12 metals (following the new ACS/IUPAC 
nomenclature) are bound as the nd” ions, that is, with 
closed shell electronic configurations. Ligand to metal, 
TIS - Cd2+ , charge transfer transitions at 250 nm [ 131 
3110~ the detection of Cd-containing MTs in vitro 
(observable because the protein itself does not exhibit 
absorption to the red of the 214 nm peptide absorp- 
tion). However, absorption from similar transitions in 
vivo are impossible to find amongst all other absorp- 
tions of the tissue components. Copper-containing MT 
exhibits weak and featureless absorption and CD spec- 
tra [12,26], quite unlike the spectra of Cd,-MT [14], so 
the problem of observing Cu-MT in tissue directly by 
absorption or CD is even more difficult. 
Since the excess copper present in Wilson’s patient’s 
liver and stimulated in rat livers by subcutaneous injec- 
tions of copper salts, is predominantly bound to MT, 
we interpret the spectroscopic results obtained from the 
liver tissue in this study, as emission from Cu-MT that 
is located in the liver tissue. The emission is only observ- 
ed for copper-enhanced tissue, the emission and excita- 
tion maxima are consistent with luminescence from the 
Cu(I)-S chromophore, and, finally, while emission in 
the red region of the spectrum is relatively unusual, it 
has been reported that many complexes of Cu(1) emit at 
low temperatures. 
This experimental measurement offers a new method 
for determining directly the location of copper(I) bound 
to MT in liver tissue as a specific staining method for 
Cu. The procedure will also be able to provide in the 
future much more detailed information about copper 
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binding to MT in vivo. Emission spectra have been 
reported for many metallorganic complexes of Cu(1) 
[27-291, although not yet in detail for any of the MT- 
binding site models. Thus this new technique may pro- 
vide a means of determining for the first time, the ex- 
tent of copper-sulfur cluster formation and the actual 
copper-protein stoichiometry in tissue, by comparing 
the photophysical parameters measured for Cu-MT in 
vivo, with the parameters obtained for Cu-MT formed 
in vitro. 
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